Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bardou

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Influence of apolipoprotein E polymorphism in alcoholic cirrhosis]V Giraud, S Naveau, D Betoulle, et al.
British Journal of Pharmacology|February 9, 2010
SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitisF Lirussi, M O'Brien, M Wendremaire, et al.
Gut|January 5, 2002
Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control studyM Bardou, S Montembault, V Giraud, et al.
European Journal of Clinical Pharmacology|February 7, 2002
Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in FranceF Clinard, M Bardou, C Sgro, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[Descriptive epidemiology of patients with alcoholic liver disease hospitalized in a hepato-gastroenterology service]S Naveau, E Borotto, V Giraud, et al.
Journal of Cardiovascular Pharmacology|August 3, 2001
Hypoxic vasoconstriction of rat main pulmonary artery: role of endogenous nitric oxide, potassium channels, and phosphodiesterase inhibitionM Bardou, F Goirand, S Marchand, et al.
European Journal of Pharmacology|September 3, 1998
In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effectM Bardou, B Dousset, C Deneux-Tharaux, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2004
Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancyC Rouget, M Bardou, M Breuiller-Fouché, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2012
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matchingI Le Ray, S Dabakuyo, G Crehange, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 1999
Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometriumM Bardou, J Cortijo, C Loustalot, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Influence of apolipoprotein E polymorphism in alcoholic cirrhosis]V Giraud, S Naveau, D Betoulle, et al.
British Journal of Pharmacology|February 9, 2010
SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitisF Lirussi, M O'Brien, M Wendremaire, et al.
Gut|January 5, 2002
Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control studyM Bardou, S Montembault, V Giraud, et al.
European Journal of Clinical Pharmacology|February 7, 2002
Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in FranceF Clinard, M Bardou, C Sgro, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[Descriptive epidemiology of patients with alcoholic liver disease hospitalized in a hepato-gastroenterology service]S Naveau, E Borotto, V Giraud, et al.
Journal of Cardiovascular Pharmacology|August 3, 2001
Hypoxic vasoconstriction of rat main pulmonary artery: role of endogenous nitric oxide, potassium channels, and phosphodiesterase inhibitionM Bardou, F Goirand, S Marchand, et al.
European Journal of Pharmacology|September 3, 1998
In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effectM Bardou, B Dousset, C Deneux-Tharaux, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2004
Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancyC Rouget, M Bardou, M Breuiller-Fouché, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2012
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matchingI Le Ray, S Dabakuyo, G Crehange, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 1999
Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometriumM Bardou, J Cortijo, C Loustalot, et al.
Pageof 4